<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0009" orientation="portrait" position="float">
 <label>Figure 9.</label>
 <caption>
  <p>Pharmacokinetic profiles of dapagliflozin (DN) after a single oral administration of formulation (F1-SNEDDS: BSO/CMCM/CrEL [15/35/50%w/w]) and control (marketed drug) to male Wister rats at a dose equivalent to 6 mg/kg dapagliflozin (Mean ± SEM, 
   <italic>n</italic> = 6). * denotes the significance as 
   <italic>p</italic> &lt; .05. 
   <italic>C</italic>
   <sub>max</sub>: peak of maximum concentration; AUC
   <sub>0→t</sub>: area under the concentration time profile curve up to time 24 h; AUC
   <sub>0→∞</sub>: area under the concentration time profile curve extrapolated to infinity; 
   <italic>V</italic>
   <sub>d</sub>: volume of distribution at steady state; 
   <italic>T</italic>
   <sub>1/2</sub>: half-life; MRT: mean residence time; CL: oral clearance.
  </p>
 </caption>
 <graphic content-type="color" xlink:href="IDRD_A_1859001_F0009_C" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
